Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 80.59B | 73.79B | 63.12B | 50.30B | 41.67B | 33.05B |
Gross Profit | 54.09B | 48.10B | 39.99B | 33.64B | 28.10B | 23.85B |
EBITDA | 33.81B | 31.47B | 23.22B | 20.62B | 15.98B | 12.72B |
Net Income | 20.04B | 18.71B | 13.48B | 24.15B | 8.82B | 7.62B |
Balance Sheet | ||||||
Total Assets | 368.13B | 344.70B | 292.35B | 273.41B | 215.46B | 192.02B |
Cash, Cash Equivalents and Short-Term Investments | 185.63B | 174.76B | 138.96B | 130.47B | 106.52B | 100.83B |
Total Debt | 48.08B | 53.10B | 49.11B | 42.68B | 34.75B | 35.75B |
Total Liabilities | 255.90B | 238.88B | 197.54B | 184.15B | 157.64B | 158.57B |
Stockholders Equity | 109.23B | 102.90B | 92.27B | 87.12B | 55.85B | 31.73B |
Cash Flow | ||||||
Free Cash Flow | 52.09B | 45.03B | 1.50B | 4.69B | -8.27B | 47.25B |
Operating Cash Flow | 52.60B | 49.47B | 6.13B | 7.66B | -6.34B | 49.19B |
Investing Cash Flow | -11.63B | -5.23B | 17.76B | -2.44B | 2.23B | -4.49B |
Financing Cash Flow | -16.40B | -3.73B | -6.42B | 2.64B | 12.78B | -785.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | 7.26B | 18.41 | ― | 1.05% | 7.69% | -6.56% | |
76 Outperform | 12.61B | 29.53 | ― | 0.42% | 21.21% | 82.61% | |
74 Outperform | 13.66B | 12.61 | 12.16% | 3.86% | 7.76% | 30.00% | |
66 Neutral | $627.14B | 31.29 | 19.13% | 1.51% | 14.62% | 16.47% | |
61 Neutral | 154.85B | 50.56 | 9.58% | 0.13% | 26.40% | 129.49% | |
56 Neutral | 135.93B | 56.55 | 9.77% | 0.12% | 45.51% | 292.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
GMO Payment Gateway reported a 12.6% increase in revenue for the nine months ending June 30, 2025, with operating profit rising by 20.1%. The company has also included a new subsidiary, GMO Enpay, Inc., in its consolidation, indicating strategic expansion. Despite the positive financial performance, total comprehensive income saw a decline of 13.0%, which may impact stakeholder confidence.
The most recent analyst rating on (JP:3769) stock is a Buy with a Yen10650.00 price target. To see the full list of analyst forecasts on GMO Payment Gateway stock, see the JP:3769 Stock Forecast page.
GMO Payment Gateway, Inc. announced the issuance of its first and second unsecured straight bonds, each amounting to 10 billion yen. The proceeds from these bonds will primarily be used for redeeming existing convertible bonds due in 2026, with any surplus directed towards working capital or investment purposes. This strategic financial move is expected to strengthen the company’s liquidity and support its operational and investment activities.
The most recent analyst rating on (JP:3769) stock is a Hold with a Yen9300.00 price target. To see the full list of analyst forecasts on GMO Payment Gateway stock, see the JP:3769 Stock Forecast page.